Filing Flows

Filing Flows › Spire Global (SPIR) › Q1 2026 › vs Q1 2025

Spire Global (SPIR) Q1 2026 vs Q1 2025 (year over year)

Spire Global's revenue fell $8.0M (-34%) from $23.9M in Q1 2025 to $15.8M in Q1 2026. The biggest changes: Subscription Based Contract −$6.3M (-32%); Non Subscription Based Contracts −$1.8M (-40%).

Spire Global, Q1 2026: revenue $15.8M (-34% year over year), operating margin -155.2%, net loss $25.8M, operating cash flow −$26.2M. The chart draws each line against Q1 2025, the increases inside each band.

Spire Global: what changed, Q1 2026 vs Q1 2025Spire Global: what changed, Q1 2026 vs Q1 2025Cash used in operations$17.8MOperating cash sources$15.4MWorking capital & other$13.1MOperating costs−$11.8MCosts & expenses−$10.5MSubscription Based Contract−$6.3MInterest & other, net$6.0MCost of revenue−$5.6MOther operating costs−$4.3MSales & marketing−$2.4M

Every line

LineQ1 2026Q1 2025Change%
Subscription Based Contract$13.2M$19.5M−$6.3M-32%
Non Subscription Based Contracts$2.6M$4.4M−$1.8M-40%
Revenue$15.8M$23.9M−$8.0M-34%
Net loss$25.8M$23.5M$2.3M+10%
Costs & expenses$41.7M$52.2M−$10.5M-20%
Operating costs$40.4M$52.2M−$11.8M-23%
Interest & other, net$1.2M−$4.8M$6.0M—
Income tax$55K−$6K$61K—
Cost of revenue$9.5M$15.2M−$5.6M-37%
Research & development$8.7M$8.7M$40K+0.5%
Sales & marketing$3.1M$5.5M−$2.4M-43%
General & admin$18.1M$17.6M$476K+3%
Other operating costs$909K$5.2M−$4.3M-82%
Operating cash sources$33.2M$17.7M$15.4M+87%
Depreciation & amortization$3.0M$4.4M−$1.4M-32%
Share-based compensation$4.0M$4.9M−$942K-19%
Cash used in operations$26.2M$8.4M$17.8M+211%
Net loss absorbed$25.8M$23.5M$2.3M+10%
Working capital & other$7.3M−$5.8M$13.1M—

Questions

How much did Spire Global's revenue grow year over year in Q1 2026?

Spire Global's revenue fell $8.0M (-34%) from $23.9M in Q1 2025 to $15.8M in Q1 2026.

What drove Spire Global's revenue change in Q1 2026?

Subscription Based Contract −$6.3M (-32%); Non Subscription Based Contracts −$1.8M (-40%).

Q1 2026 results → · Compare in the interactive Sankey →